Difference between revisions of "About Us"
Jump to navigation
Jump to search
| [unchecked revision] | [unchecked revision] |
| Line 16: | Line 16: | ||
The global hub for clinical cancer genomic aberrations. | The global hub for clinical cancer genomic aberrations. | ||
| + | |||
| + | |||
| + | '''Support''' | ||
| + | |||
| + | The CCGA is a Cancer Genomics Consortium (CGC)-supported resource. | ||
Revision as of 16:19, 11 May 2021
Mission
The CCGA is a global collaborative effort to describe clinical context-based knowledge for gene- and chromosome-level abnormalities observed in cancer.
Goals
- Provide a centralized resource of genetic correlates for pathologic entities, structured based on current disease-level WHO classification system, with direct links to significant internal and external site content.
- Support real-time updating and sharing of clinically relevant content that is peer-reviewed and easily searchable.
- Engage community experts and their trainees in curating, updating and utilizing content.
- Include cancer variant knowledge identified through diverse methods and across multiple disciplines.
- Facilitate building educational content that describes the latest advancements in the field.
Vision
The global hub for clinical cancer genomic aberrations.
Support
The CCGA is a Cancer Genomics Consortium (CGC)-supported resource.
Leadership
Meet our Editorial Leadership, CCGA Workgroup Members and Communications Liaison.